Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
33.87
-0.17 (-0.50%)
At close: Mar 6, 2026, 4:00 PM EST
34.54
+0.67 (1.98%)
After-hours: Mar 6, 2026, 7:52 PM EST
Corcept Therapeutics Employees
Corcept Therapeutics had 730 employees as of December 31, 2025. The number of employees increased by 230 or 46.00% compared to the previous year.
Employees
730
Change (1Y)
230
Growth (1Y)
46.00%
Revenue / Employee
$1,043,023
Profits / Employee
$134,481
Market Cap
3.60B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,609 |
| ACADIA Pharmaceuticals | 798 |
| ADMA Biologics | 685 |
| Crinetics Pharmaceuticals | 594 |
| Xenon Pharmaceuticals | 370 |
| Alumis | 223 |
| Centessa Pharmaceuticals | 114 |
| Spyre Therapeutics | 102 |
CORT News
- 4 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 21, 2026 in Corcept Therapeutics Incorporated Lawsuit - CORT - PRNewsWire
- 10 days ago - Corcept Therapeutics Incorporated (CORT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Corcept Therapeutics Announces Fourth Quarter and Full-Year 2025 Audited Financial Results, Provides Corporate Update - Business Wire
- 15 days ago - Corcept Therapeutics: The Bad News Is Priced In; The Ovarian Cancer Upside Is Not - Seeking Alpha
- 16 days ago - Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals - Business Wire
- 16 days ago - Corcept Therapeutics Stock Plunges As Court Clears Teva Generic - Benzinga
- 18 days ago - Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call - Business Wire
- 26 days ago - CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm - GlobeNewsWire